Related Experiment Video
Updated: Jun 6, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Emerging antiretroviral drug interactions.
1Division of Infectious Diseases, Johns Hopkins University, School of Medicine, Baltimore, MD 21287, USA. vpham@jhmi.edu
The Journal of Antimicrobial Chemotherapy
|December 7, 2010
Summary
As people with HIV live longer, earlier antiretroviral therapy (ART) initiation increases drug-drug interaction risks. Clinicians must recognize significant interactions between ART and medications for co-morbidities to optimize treatment and minimize toxicity.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Medicine
Background:
- Increasing lifespans of HIV-infected patients necessitate earlier antiretroviral therapy (ART) initiation.
- This trend elevates the risk of drug-drug interactions (DDIs) between ART and medications for co-morbid conditions.
- Recognizing significant DDIs is crucial for maximizing ART efficacy and minimizing toxicity.
Purpose of the Study:
- To identify and highlight clinically significant drug-drug interactions.
- Focus on interactions between newer antiretroviral agents and common co-administered medications.
- Provide guidance for clinicians managing complex HIV treatment regimens.
Main Methods:
- Literature review and analysis of published data on drug-drug interactions.
- Focus on specific newer antiretroviral drugs: darunavir, raltegravir, maraviroc, and etravirine.
- Examination of interactions with antituberculosis, antimalarial, anticoagulant, chemotherapeutic, and pulmonary antihypertensive agents.
Main Results:
- Significant DDIs exist between newer ART and various co-administered drug classes.
- Specific interactions identified with antituberculosis agents, antimalarials, anticoagulants, chemotherapy, and pulmonary antihypertensives.
- These interactions can alter the efficacy and safety profiles of both ART and concurrent medications.
Conclusions:
- Clinicians must be vigilant regarding potential DDIs when prescribing newer ART.
- Awareness of these interactions is essential for safe and effective management of co-morbidities in HIV patients.
- Proactive management of DDIs ensures optimal clinical outcomes and patient safety.
More Related Videos
Related Concept Videos
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:30Combined Effects of Drugs: Antagonism
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...